International Stem Cell CORP
ISCO· OTC
Released Aug 7, 2013, after the close
10-Q filed Aug 8, 2013, 39 days after period end · 0001193125-13-324958
| Metric | Q2 2013 | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|---|
| Revenue | $1.46M | $1.06M | $1.11M | $441.12K |
| Net Income | -$2.20M | -$2.48M | -$2.39M | $4.23M |
| EPS Diluted |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| -$0.02 |
| -$0.03 |
| -$0.03 |
| $0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.